Bristol-Myers Rises After Report That Carl Icahn Owns Stake
- DJ report says Icahn sees drugmaker as takeover target
- Co. earlier named 3 directors after talks with holder Jana
This article is for subscribers only.
Bristol Myers Squibb Co. shares rose as much as 4.8 percent after Dow Jones reported that activist investor Carl Icahn has taken a stake in the drugmaker and sees it as a possible takeover target.
Icahn owns a large stake, Dow Jones said, citing people familiar with the matter. It isn’t clear how large the holding is, the news agency said.